Google DeepMind and Yale University's collaborative latest AI model, Cell2Sentence-Scale 27B, identified a treatment that can make "cold" tumours more visible to the immune system. "Cold" tumours pose as one of the biggest challenges in cancer immunotherapy as they evade detection by the immune system. Google CEO Sundar Pichai said this finding was confirmed through experiments with living cells.